Palouse Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.46M Buy
57,027
+29,275
+105% +$2.36M 2.78% 7
2026
Q1
$2.4M Sell
27,752
-1,673
-6% -$160K 1.59% 26
2025
Q4
$2.83M Sell
29,425
-997
-3% -$96.8K 1.81% 20
2025
Q3
$2.9M Sell
30,422
-29
-0.1% -$2.67K 1.84% 19
2025
Q2
$2.65M Buy
30,451
+37
+0.1% +$3.14K 1.75% 24
2025
Q1
$2.73M Sell
30,414
-221
-0.7% -$19.8K 1.87% 20
2024
Q4
$2.45M Sell
30,635
-374
-1% -$32.4K 1.63% 25
2024
Q3
$2.79M Buy
31,009
+4,810
+18% +$405K 1.76% 24
2024
Q2
$2.06M Sell
26,199
-425
-2% -$34.8K 1.38% 32
2024
Q1
$2.32M Sell
26,624
-1,614
-6% -$138K 1.53% 25
2023
Q4
$2.33M Sell
28,238
-888
-3% -$67.7K 1.64% 21
2023
Q3
$2.28M Sell
29,126
-566
-2% -$47.4K 1.69% 24
2023
Q2
$2.62M Sell
29,692
-770
-3% -$66.3K 1.83% 18
2023
Q1
$2.46M Buy
+30,462
New +$2.48M 1.66% 27

Other funds holding MDT

Palouse Capital Management's MDT Position: Q2 2026 in Review

Palouse Capital Management increased its Medtronic (MDT) stake by 105% in Q2 2026, buying an estimated $2.36M and bringing the position to 57,027 shares worth $4.46M. The position accounts for 2.78% of the portfolio, ranked #7.

Palouse Capital Management first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Palouse Capital Management held 57,027 shares of Medtronic worth $4.46M as of Q2 2026.
  • Palouse Capital Management bought 29,275 Medtronic shares in Q2 2026, an estimated $2.36M.
  • Medtronic made up 2.78% of Palouse Capital Management's portfolio in Q2 2026, its #7 holding.
  • Palouse Capital Management first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Palouse Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.